← back to search

Matthew W. Segar

Brunswick (United States) · US
Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Diabetes Treatment and Management, and Cardiovascular Health and Risk Factors.
h-index
26
citations
2,630
works
154
NIH funding
primary concept
Medicine
email

Recent publications

Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis
Circulation 2023cited by 31position: middledoi
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure
JAMA Cardiology 2022cited by 111position: firstdoi
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus
Diabetes Obesity and Metabolism 2022cited by 44position: firstdoi
Race, Social Determinants of Health, and Length of Stay Among Hospitalized Patients With Heart Failure: An Analysis From the Get With The Guidelines-Heart Failure Registry
Circulation Heart Failure 2022cited by 35position: firstdoi
Development and Validation of Machine Learning–Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis
Circulation 2021cited by 114position: firstdoi
Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
Journal of the American College of Cardiology 2021cited by 90position: firstdoi
Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes
Diabetologia 2021cited by 24position: firstdoi
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT)
JAMA Cardiology 2020cited by 48position: middledoi
Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score
Diabetes Care 2019cited by 305position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ambarish Pandey · Wake Forest University9 papers (2019–2023)Javed Butler · Jackson College5 papers (2019–2023)Kershaw V. Patel · Houston Methodist5 papers (2019–2023)Muthiah Vaduganathan · Harvard University4 papers (2019–2023)Darren K. McGuire · Saint Luke's Health System4 papers (2019–2022)Gregg C. Fonarow · UCLA Medical Center3 papers (2019–2022)Shreya Rao · New York State Psychiatric Institute3 papers (2020–2022)Adolfo Correa · Jackson Memorial Hospital2 papers (2020–2021)DuWayne L. Willett · Southwestern Medical Center2 papers (2019–2021)Byron C. Jaeger · Diagnostics for the Real World (United Kingdom)2 papers (2021–2021)Muhammad Shahzeb Khan · Temple College2 papers (2021–2023)James A. de Lemos · National Health and Medical Research Council2 papers (2020–2021)Carolyn S.P. Lam · Duke-NUS Medical School2 papers (2021–2023)Alanna A. Morris · Bayer (United States)2 papers (2020–2022)Subodh Verma · Institute for Work & Health2 papers (2021–2023)Vijay Agusala · Southwestern Medical Center1 papers (2020–2020)Utibe R. Essien · University of California, Los Angeles1 papers (2020–2020)Chiadi E. Ndumele · Center for Clinical Research (United States)1 papers (2021–2021)Colby Ayers · National Institute on Minority Health and Health Disparities1 papers (2021–2021)Andrew P. DeFilippis · Vanderbilt University Medical Center1 papers (2023–2023)